Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
A. Balderacchi (Pavia, Italy), V. Barzon (Pavia, Italy), S. Ottaviani (Pavia, Italy), M. Gorrini (Pavia, Italy), A. Corsico (Pavia, Italy), M. Zorzetto (Pavia, Italy), I. Ferrarotti (Pavia, Italy). Comparison of different algorithms in laboratory diagnosis of Alpha1-antitripsin deficiency. 4064

Member's Comments

No comment yet.

Related content which might interest you: Comparison of scoring systems use for estimation of severity of community acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Different clinical suspect that brings to the diagnosis of alpha1-antitrypsin deficiency Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Comparison of different staging methods for COPD in predicting outcomes Source: Eur Respir J, 51 (3) 1700577; 10.1183/13993003.00577-2017 Year: 2018 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 The impact of different reference standards when estimating the accuracy of tests for diagnosing asthma Source: International Congress 2018 – Primary care management of asthma Year: 2018 Comparison of morphological and densitometric indicators of the inflammatory process activity for substantiation of the optimal terms of surgical treatment in patients with various forms of TB Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020 Different clinical phenotypes of CLAD: diagnosis and outcomes Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation Year: 2015 Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001 The evaluation of noninvasive diagnosis methods in pulmonary embolism diagnosis together with two different clinical possibility methods Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006 Comparing the discriminative properties of different staging systems with regard to functional characterization of patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005 Performance of five serological tests using different antigens in rapid diagnosis of tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Applications of clinical exercise testing: different formats, different prognostic outcomes Source: International Congress 2014 – PG07 Cardiopulmonary exercise testing Year: 2014 Applications of clinical exercise testing: different formats, different prognostic outcomes Source: Annual Congress 2013 –PG14 Cardiopulmonary exercise testing in the evaluation of patients with respiratory diseases Year: 2013 Comparison of three different methods of FeNO measurement in children Source: Annual Congress 2007 - Crossroads between paediatric respiratory physiology and epidemiology Year: 2007 Comparison of different sputum examination methods to determine time for discontinuation of respiratory isolation for tuberculosis patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008 Comparison of performance in two diagnostic methods for M. tuberculosis infection Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 A simple algorithm for the identification of clinical COPD phenotypes Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017 Year: 2017 Different methods to classify COPD patients into the ABCD severity groups – Preliminary results of the LQ-DMP project Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 The clinical current of tuberculosis in patients with different genetic markers Source: Eur Respir J 2006; 28: Suppl. 50, 14s Year: 2006